3652 results for «383»
3652 results
New evidence in coronary physiology for microvascular assessment
21 May 2026 – From EuroPCR 2026
This session highlights new evidence in coronary physiology related to microvascular assessment. Topics include endothelial dysfunction in angina with non-obstructive arteries, the prognostic value of microvascular resistance metrics, natural history studies, and trials aimed at standardizing management of microvascular dysfunction.
Imaging evaluation in structural heart interventions
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive evaluation of imaging techniques applied in structural heart interventions. It covers innovative studies including the impact of Dapagliflozin on multivalvular disease post-TAVI, advanced fusion methods combining CT and echocardiography to assess aortic stenosis severity, and the clinical relevance of the fibrocalcific...
Bailout techniques for complications during primary PCI
21 May 2026 – From EuroPCR 2026
This session addresses bailout techniques during primary PCI complications. It covers a range of challenging scenarios such as coronary perforations and complex procedural issues, emphasizing rapid decision-making and effective treatment strategies to improve patient outcomes in high-stakes situations.
New platforms for coronary lesions treatment
21 May 2026 – From EuroPCR 2026
Delve into the latest developments in coronary lesion treatment platforms through this session, highlighting real-world performance data of novel drug-eluting stents like Eternia and Evermine 50. It also presents preclinical insights on biomimetic CD31-coated stents, long-term outcomes of the Fantom BRS platform, and innovative randomized trials...
Identifying and planning protected temporary mechanical circulatory support-based procedures in high-risk patients
21 May 2026 – From EuroPCR 2026
This session provides an in-depth update on protected temporary mechanical circulatory support-based procedures in high-risk cardiac patients. It covers patient identification criteria, device selection, and multidisciplinary planning to optimize outcomes in protected PCI, ventricular ablation, and surgical contexts.
Risk stratification and reperfusion strategies for acute and subacute pulmonary embolism
21 May 2026 – From EuroPCR 2026
Focus on risk stratification and reperfusion strategies for acute and subacute pulmonary embolism through this session. It discusses the impact of elective endovascular therapies in intermediate-high risk patients, intraprocedural complications, and early mortality associated with catheter interventions. Additionally, it reviews real-world outcomes of catheter-directed therapy, national...
Complication management during STEMI intervention: Czech Republic - Greece and Iraq present their cases
21 May 2026 – From EuroPCR 2026
This session presents a critical analysis of procedural strategies in primary PCI for STEMI by exploring complex cases from the Czech Republic, Greece, and Iraq. It delves into mechanisms and management of major PCI complications and highlights the role of emerging novel technologies in primary PCI...
Interventions for heart failure: insights and innovations
19 May 2026 – From EuroPCR 2026
This session presents innovations and insights into interventional treatments for heart failure. Topics include pulmonary artery denervation for combined pre- and post-capillary pulmonary hypertension, evaluation of extravascular ventricular assist devices, biomarker-guided therapy withdrawal in improved heart failure, outcomes of transcatheter iatrogenic atrial shunts, percutaneous balloon pericardiotomy...
PCI for complex left main disease
19 May 2026 – From EuroPCR 2026
This session delves into the complexities of percutaneous coronary intervention (PCI) for left main disease, emphasizing strategic approaches to dual critical lesions and innovative techniques such as excimer laser and drug-eluting balloons. It also explores hybrid strategies for treating in-stent restenosis and redo revascularisation, offering a...
CTO PCI: how to prevent and manage complications effectively?
19 May 2026 – From EuroPCR 2026
Focused on chronic total occlusion (CTO) PCI, this session highlights the critical importance of procedural planning to minimize complications. Through detailed case analyses of coronary dissection and perforation, it outlines early identification strategies and equips clinicians with essential tools and techniques for effective complication management in...
The thin line between success and failure in MedTech start ups - Lessons learnt
18 May 2026 – From EuroPCR 2026
This session examines critical success factors for MedTech start-ups through real-world examples, discussing challenges, investment dynamics, and the pivotal role of the Chief Medical Officer and investor syndicates in fostering sustainable growth.
New evidence for pharmacology for coronary artery disease
19 May 2026 – From EuroPCR 2026
This session presents the latest evidence in pharmacological management of coronary artery disease, featuring pivotal trials such as VESALIUS-CV and TARGET FIRST. It covers topics including evolocumab efficacy post-stenting, early aspirin cessation strategies, aspirin-free protocols after complex PCI in ACS, and comparative outcomes of clopidogrel versus...
Abstract submissions - Nurses and Allied Professionals
19 May 2026 – From EuroPCR 2026
Dedicated to nurses and allied professionals, this session addresses occupational health challenges, radiation dose reduction through AI-enhanced fluoroscopy, and innovative simulation techniques for ECMO-supported resuscitation. It also explores sustainable practices in cath labs and the integration of structured physiotherapy pathways within TAVI programmes, underscoring multidisciplinary contributions...
Personalised vascular care Award - Competition
19 May 2026 – From EuroPCR 2026
This competitive session showcases pioneering research in personalised vascular care, featuring presentations on AI-driven medical research algorithms, machine learning for MACE prediction, and AI-enabled remote monitoring for TAVI patients. It also discusses microcirculatory resistance indices in ANOCA endotypes and includes interactive jury and audience engagements, culminating...
PCR's Got Talent Round 1 - Session 2
19 May 2026 – From EuroPCR 2026
PCR's Got Talent Round 1 - Session 2 offers a diverse collection of studies addressing coronary microvascular dysfunction, atrial fibrillation management, TAVI outcomes, AI applications in imaging, mitral and tricuspid valve interventions, and in-stent restenosis treatment. The session culminates with deliberations and results announcements, reflecting cutting-edge...
AI for clinical and academic cardiology knowledge work: innovation or academic misconduct ? Literature search, data extraction and responsible use
19 May 2026 – From EuroPCR 2026
This session critically examines the role of artificial intelligence in clinical and academic cardiology, focusing on its application in literature search, evidence synthesis, and report structuring. It discusses responsible AI use, emphasizing the balance between assistance and academic integrity, and features a debate on authorship, transparency,...
Artificial intelligence and advanced imaging in coronary interventions
19 May 2026 – From EuroPCR 2026
This session explores the integration of artificial intelligence with advanced imaging modalities in coronary interventions. Topics include quantitative myocardial blood flow assessment via co-registered CCTA and angiography, AI-guided real-time procedural support, novel video frame interpolation techniques, high-risk plaque identification through AI-derived OCT stress mapping, and validation...
Managing complex calcified PCI: pitfalls and complications
20 May 2026 – From EuroPCR 2026
This session addresses the complexities and challenges of performing PCI in heavily calcified coronary lesions. Emphasizing the critical role of imaging in procedural planning, it updates on contemporary tools and techniques to mitigate complications. The session also shares practical experience in managing common complications such as...
Pulmonary valve: the next frontier in adult structural interventions
19 May 2026 – From EuroPCR 2026
This session highlights the evolving role of the pulmonary valve in adult structural interventions. It reviews complex transcatheter pulmonary valve replacement (TPVR) cases, strategies for managing challenging right ventricular outflow tract anatomies, and percutaneous solutions for pulmonary artery stenosis and related complications.
Insight from recent evidence in structural heart disease: indications for LAA closure (CHAMPION) and PCI in TAVI candidates (PRO-TAVI)
20 May 2026 – From EuroPCR 2026
This session reviews recent evidence impacting the management of structural heart disease, focusing on left atrial appendage (LAA) closure indications and PCI considerations in transcatheter aortic valve implantation (TAVI) candidates. It discusses optimal strategies for coronary artery disease in TAVI patients and evaluates findings from the...
